Related Experiment Video
Updated: Jul 19, 2026
18:46
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
[Development and estimation of nanosomal rifampicin]
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]
|October 5, 2006
Summary
Researchers developed rifampicin-loaded nanoparticles for tuberculosis treatment. Surface modification enhanced lung drug delivery, improving bacterial clearance and chemotherapy efficacy.
Area of Science:
- Nanomedicine
- Pharmacology
- Infectious Diseases
Context:
- Tuberculosis (TB) remains a significant global health challenge, necessitating improved drug delivery systems.
- Rifampicin is a first-line anti-TB drug, but its efficacy can be limited by biodistribution.
- Polybutylcyanoacrylate nanoparticles offer a potential platform for targeted drug delivery.
Purpose:
- To develop and characterize rifampicin-loaded polybutylcyanoacrylate nanoparticles (nanosames).
- To investigate the effect of nanoparticle surface modification (poloxamer 407, poloxamine 908) on rifampicin biodistribution in mice.
- To evaluate the impact of optimized nanoparticle formulation on anti-TB chemotherapy efficacy.
Summary:
- A lab-scale method for preparing rifampicin-loaded polybutylcyanoacrylate nanoparticles was established.
- Intravenous administration in mice showed that unmodified nanoparticles led to significant liver and spleen accumulation of rifampicin.
- Surface modification with poloxamer 407 or poloxamine 908 altered biodistribution, increasing lung and plasma rifampicin concentrations while decreasing liver accumulation.
- Enhanced lung accumulation of rifampicin improved bacterial clearance in mice infected with Mycobacterium tuberculosis.
Impact:
- Surface-modified nanoparticles effectively optimize drug biodistribution for enhanced anti-infective chemotherapy.
- This nanomedicine approach shows promise for improving the treatment of lung infections like tuberculosis.
- The study highlights the potential of tailored nanoparticle design in overcoming drug delivery challenges in infectious disease treatment.
